Ledger.Open graph →
SEC Form D · Amendment · filed February 17, 2016

OrPro Therapeutics, Inc

Offering
—
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Mary J. Johnson · San Diego, CADirectorCam L. Garner · Del Mar, CAExec · DirectorJeffrey W. Raser · San Diego, CADirectorJames W. Weil · San Diego, CADirectorPeter B. Heifetz, Ph.D · San Diego, CAExec · DirectorDaniel C. Budde · BOSTON, MADirectorBrian A. Albert · BOSTON, MADirectorEtienne D. Dumais · Montreal, Quebec, CanadaExec · DirectorTammy A. Pendergast · Southport, CTDirectorStephen J. Blewitt · BOSTON, MAExec · DirectorPaul A. Fishbin · BOSTON, MADirectorScott A. Mcfetridge · BOSTON, MAExec · DirectorScott B. Garfield · BOSTON, MADirectorTheophilus Ulmer · Austin, TXDirectorMartin J. Duvall · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗